Monalizumab and ANKET™ Data will be Presented at ESMO 2021 Virtual Congress
Innate Pharma to Participate in Upcoming Investor Conferences
Number of Shares and Voting Rights of Innate Pharma as of August 1, 2021
Number of Shares and Voting Rights of Innate Pharma as of July 1, 2021
Update on Avdoralimab Phase 2 FORCE Trial in COVID-19 Patients with Severe Pneumonia
Innate Pharma Presents Preliminary Data from TELLOMAK Trial Showing Clinical Response for Lacutamab in Mycosis Fungoides
Innate Pharma to Host Virtual Investor Event to Highlight Progress Against Company Strategy
Number of Shares and Voting Rights of Innate Pharma as of June 1, 2021
Innate Pharma Presents New Data on Next-Generation NK Cell Engager Platform at FOCIS 2021 Annual Meeting
New Lacutamab Data from TELLOMAK Trial to be Showcased in Oral Presentation at Upcoming 16th International Conference on Malignant Lymphoma
